Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -12.13x is 96% above its 5-year average of -294.36x, near the high end of its 5-year range (-1280.50x–-3.67x).
7.52% below its 12-month average of -11.28x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3.67x.
INTEREST COVERAGE RATIO
-12.13x
INTEREST COVERAGE RATIO AVG TTM
-11.28x
INTEREST COVERAGE RATIO AVG 3Y
-12.05x
INTEREST COVERAGE RATIO AVG 5Y
-294.36x
INTEREST COVERAGE RATIO AVG 10Y
-151.37x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.52%
CURRENT VS 3Y AVG
-0.70%
CURRENT VS 5Y AVG
+95.88%
CURRENT VS 10Y AVG
+91.99%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-90.27%
vs the sector median at left
Ocugen, Inc.
Market Cap
$356.07M
Interest Coverage Ratio
-12.13x
TTM Avg
-11.28x
3Y Avg
-12.05x
5Y Avg
-294.36x
Market Cap
$356.36M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$356.57M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$356.92M
Interest Coverage Ratio
17.52x
TTM Avg
20.30x
3Y Avg
29.07x
5Y Avg
34.22x
Market Cap
$357.58M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$358.04M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$353.63M
Interest Coverage Ratio
-45.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$353.52M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$348.23M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocugen, Inc. (OCGN) | $356.07M | -12.13x | -11.28x | -12.05x | -294.36x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $356.36M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $356.57M | N/A | N/A | N/A | N/A |
| Viemed Healthcare, Inc. (VMD)vs › | $356.92M | 17.52x | 20.30x | 29.07x | 34.22x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $357.58M | -3.05x | 0.61x | 0.61x | 0.61x |
| Embecta Corp. (EMBC)vs › | $358.04M | 3.07x | 2.31x | 3.74x | 3.74x |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $353.63M | -45.13x | N/A | N/A | N/A |
| Turn Therapeutics Inc. (TTRX)vs › | $353.52M | N/A | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $365.52M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
Interest Coverage
-12.1x
Debt/Equity
N/A
Current Ratio
0.80
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3.67x |
| 2026-03-31 | -13.51x |
| 2025-12-31 | -12.77x |
| 2025-09-30 | -13.41x |
| 2025-06-30 | -13.04x |
| 2025-03-31 | -15.87x |
| 2021-12-31 | -728.60x |
| 2021-09-30 | -567.84x |
| 2021-06-30 | -1280.50x |
| 2021-03-31 | -352.85x |
| 2020-12-31 | -22.91x |
| 2020-09-30 | -34.88x |
| 2020-06-30 | -13.56x |
| 2020-03-31 | -266.39x |
| 2019-12-31 | -291.82x |
| 2019-09-30 | -3.41x |
| 2019-06-30 | -437.14x |
| 2018-06-30 | -227.63x |
| 2018-03-31 | -164.68x |
| 2017-12-31 | -45.02x |
| 2017-09-30 | -146.49x |
| 2017-06-30 | -159.35x |
| 2017-03-31 | -195.14x |
| 2016-12-31 | -161.35x |
| 2016-09-30 | -2.16x |
| 2016-06-30 | -467.94x |
| 2016-03-31 | -410.42x |
| 2015-12-31 | -377.91x |
| 2015-09-30 | -349.52x |
| 2015-06-30 | -292.04x |
| 2015-03-31 | -126.98x |
| 2014-12-31 | -49.54x |
| 2014-09-30 | -786.32x |
